Blue Shield of California bypasses PBMs to slash Humira prices by 90%

In a bold move to tackle soaring drug costs, Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers (PBMs) to bring blockbuster drugs to patients at a fraction of the cost. By partnering directly with manufacturers, the insurer aims to dramatically reduce the price of AbbVie's Humira, the world's top-selling drug, by up to 90%.